Magnesium sulfate given intravenously to pregnant women at risk of very preterm birth was not associated with benefit on neurological, behavioral, growth, or functional outcomes in their children at ...

STANFORD, Calif., July 2 -- Compared with nifedipine (Procardia), magnesium sulfate was significantly more likely to cause serious maternal side effects when used to prevent preterm labor. These side ...

Cerebral palsy (CP) is the most prevalent chronic childhood motor disability with an estimated lifetime cost of nearly $1 million per individual. There is evidence that magnesium sulfate (MgSO4) can ...

Short-term (usually less than 48 hours) use of magnesium sulfate in obstetric care is appropriate for certain conditions and durations of treatment, according to a committee opinion from the American ...

High-dosage, tocolytic magnesium sulfate (MgSO 4) administered to pregnant women during preterm labor can be toxic, and sometimes lethal, for their newborns (Cochrane Database of Systematic Reviews ...

Clinicians should not administer magnesium sulfate to pregnant women for the off-label use of stopping preterm labor for more than 5 to 7 days, lest the treatment lead to low calcium levels and bone ...

The study protocol was approved by the local ethics committee, and the experimental procedures were in accordance with the Guide for Care and Use of Laboratory Animals of the National Institutes of ...

In this multicenter, placebo-controlled, double-blind trial, we randomly assigned women at imminent risk for delivery between 24 and 31 weeks of gestation to receive magnesium sulfate, administered ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Magnesium Sulfate Concentrated Injection contains the active ...

Magnesium sulfate given intravenously to pregnant women at risk of very preterm birth was not associated with benefit on neurological, behavioral, growth, or functional outcomes in their children at ...